Harbin Pharmaceutical Group Co Ltd (600664.SS)
24 Nov 2020
Latest Key Developments (Source: Significant Developments)
Aug 30 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS H1 NET LOSS AT 42.3 MILLION YUAN ($5.96 million) VERSUS NET PROFIT OF 363.0 MILLION YUAN YEAR EARLIER. Full Article
May 27 (Reuters) - Harbin Pharmaceutical Group Co Ltd <600664.SS>::SAYS CONTROLLING SHAREHOLDER PLANS TO SELL 20% STAKE FOR 1.7 BILLION YUAN ($246.45 million) TO UP TO THREE SHAREHOLDERS. Full Article
WASHINGTON, Sept 10 U.S. Senator Marco Rubio, a Republican and a China hawk, asked for a national security review of plans by General Nutrition Centers, or GNC, to sell itself to Harbin Pharmaceutical Group Co Ltd.